Israel Englander Cor Medix Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cor Medix Inc. stock. As of the latest transaction made, Millennium Management LLC holds 395,454 shares of CRMD stock, worth $4.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

395,454

Previous 56,286 602.58%

Holding current value

$4.48 Million

Previous $693,000 582.97%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$10.07 - $14.83 $3.42 Million - $5.03 Million	339,168 Added 602.58%	395,454 $4.73 Million
Q2 2025 Aug 14, 2025	SELL	$5.86 - $16.56 $1.84 Million - $5.21 Million	-314,840 Reduced 84.83%	56,286 $693,000
Q1 2025 May 15, 2025	BUY	$6.16 - $12.57 $1.19 Million - $2.43 Million	192,992 Added 108.34%	371,126 $2.29 Million
Q4 2024 Feb 14, 2025	BUY	$8.1 - $13.59 $711,957 - $1.19 Million	87,896 Added 97.4%	178,134 $1.44 Million
Q3 2024 Nov 14, 2024	SELL	$3.64 - $8.23 $1.3 Million - $2.93 Million	-356,514 Reduced 79.8%	90,238 $729,000

Q2 2024 Aug 14, 2024	BUY	$4.08 - $6.39 $1.78 Million - $2.78 Million	435,644 Added 3921.89%	446,752 $1.93 Million
Q1 2024 May 15, 2024	SELL	$2.94 - $4.24 $814,809 - $1.18 Million	-277,146 Reduced 96.15%	11,108 $47,000
Q4 2023 Feb 14, 2024	SELL	$3.0 - $4.01 $689,235 - $921,277	-229,745 Reduced 44.35%	288,254 $1.08 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $5.8 $807,806 - $1.19 Million	205,027 Added 65.51%	517,999 $2.05 Million
Q1 2023 May 15, 2023	SELL	$3.22 - $4.61 $867,677 - $1.24 Million	-269,465 Reduced 46.27%	312,972 $1.3 Million
Q4 2022 Feb 14, 2023	BUY	$2.81 - $4.45 $37,035 - $58,651	13,180 Added 2.32%	582,437 $2.46 Million
Q3 2022 Nov 14, 2022	SELL	$2.82 - $7.52 $329,923 - $879,794	-116,994 Reduced 17.05%	569,257 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $1.81 Million - $3.73 Million	664,473 Added 3051.12%	686,251 $2.76 Million
Q1 2022 May 16, 2022	BUY	$3.83 - $6.24 $83,409 - $135,894	21,778 New	21,778 $119,000
Q4 2020 Feb 16, 2021	SELL	$5.0 - $9.15 $535,230 - $979,470	-107,046 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.96 - $6.15 $423,902 - $658,332	107,046 New	107,046 $645,000
Q4 2019 Feb 14, 2020	SELL	$4.96 - $7.75 $125,582 - $196,222	-25,319 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$6.38 - $9.69 $218,948 - $332,541	-34,318 Reduced 57.54%	25,319 $161,000
Q2 2019 Aug 15, 2019	BUY	$5.93 - $10.57 $262,224 - $467,405	44,220 Added 286.83%	59,637 $535,000
Q2 2019 Aug 14, 2019	SELL	$5.93 - $10.57 $1.28 Million - $2.28 Million	-215,506 Reduced 93.32%	15,417 $33,000
Q1 2019 May 14, 2019	BUY	$6.95 - $13.25 $1.6 Million - $3.06 Million	230,923 New	230,923 $2.18 Million

Others Institutions Holding CRMD

# of Institutions

204

Shares Held

41.2M

Call Options Held

1.33M

Put Options Held

1.3M

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $467M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account